Among them, melanoma, pathway in cancer, basal cell carcinoma, bladder cancer, renal cell carcinoma and pancreatic cancer prove that COL10A1 affects the occurrence and development of cancer. This evidence concerns the gene COL10A1 and renal cell carcinoma.